ACRV
Acrivon Therapeutics, Inc.
1.90$
-6.1%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 95.6% | 93.8% | 93.0% | 79.1% | 88.0% | 92.4% | 85.8% | 87.3% | 89.7% | 92.9% | 92.0% | 92.3% | |
| 19.8% | 26.0% | 20.4% | 20.0% | 20.2% | 20.3% | 22.2% | 26.4% | 24.4% | 32.0% | 31.6% | 41.8% | |
| 94.0% | 92.2% | 91.2% | 78.3% | 87.3% | 91.3% | 84.9% | 86.7% | 89.0% | 91.4% | 90.6% | 90.8% | |
| 8.6% | 12.3% | 10.4% | 6.3% | 8.3% | 10.1% | 9.0% | 9.8% | 11.5% | 13.3% | 11.4% | 12.5% | |
| 6.2% | 9.6% | 7.5% | 4.9% | 6.9% | 8.8% | 7.7% | 8.5% | 10.2% | 12.1% | 10.3% | 11.6% | |
| 0.5% | 0.6% | 0.8% | 0.4% | 0.5% | 0.5% | 0.6% | 0.7% | 0.8% | 0.9% | 1.1% | 1.1% | |
| 1.0% | 3.7% | 1.7% | 0.5% | 0.7% | 0.4% | 2.1% | 0.7% | 0.7% | 1.8% | 1.1% | 0.9% | |
| 91.4% | 87.7% | 89.6% | 93.7% | 91.7% | 89.9% | 91.0% | 90.2% | 88.5% | 86.7% | 88.6% | 87.5% | |
| -64.3% | -84.2% | -110.3% | -65.8% | -81.1% | -100.2% | -122.9% | -149.9% | -176.1% | -211.9% | -272.6% | -314.7% | |
| 14.6% | 16.2% | 18.7% | 15.7% | 17.7% | 19.5% | 21.7% | 24.3% | 26.5% | 29.7% | 35.9% | 42.2% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.